Toru Naganuma

Showing 1-9 of 9 articles

Silent Valsalva thrombus between the native Valsalva and balloon-expandable transcatheter heart valve: multicentre Japanese registry analysis

Tsunaki T, Yamamoto M, Shimura T, Kagase A, Naganuma T, Higashimori A, Araki M, Yamanaka F, Mizutani K, Watanabe Y, Otsuka T, Yanagisawa R, Hayashida K

November 15, 2019 | 10.4244/EIJ-D-19-00370

Coronary interventions

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S

April 20, 2017 | 10.4244/EIJ-D-16-00974

Coronary interventions

Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy

Tanaka A, Latib A, Kawamoto H, Jabbour R, Sato K, Miyazaki T, Naganuma T, Mangieri A, Pagnesi M, Montalto C, Chieffo A, Carlino M, Montorfano M, Colombo A

February 20, 2017 | 10.4244/EIJ-D-16-00247

Coronary interventions

Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds

Panoulas V, Miyazaki T, Sato K, Naganuma T, Sticchi A, Kawamoto H, Figini F, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A

March 18, 2016 | 10.4244/EIJY15M03_11

Coronary interventions

Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations

Naganuma T, Latib A, Costopoulos C, Oreglia J, Testa L, De Marco F, Candreva A, Chieffo A, Naim C, Montorfano M, Bedogni F, Colombo A

January 20, 2016 | 10.4244/EIJY14M11_01

How should I treat multiple coronary aneurysms with severe stenoses?

Warisawa T, Naganuma T, Nakamura S

November 20, 2015 | 10.4244/EIJV11I7A171

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C

February 20, 2015 | 10.4244/EIJY14M07_11

Percutaneous intervention of calcific coronary lesions

Costopoulos C, Naganuma T, Colombo A

March 3, 2014

Tools and Techniques Clinical: Percutaneous intervention of calcific coronary lesions

Costopoulos C, Naganuma T, Colombo A

January 20, 2014 | 10.4244/EIJV9I9A188

Latest news

NEW ISSUE

State-of-the-Art on Glucose Management, Diabetes and PCI; a Mini Focus on CTOs and more...

October 1, 2021

AHEAD OF PRINT

The FAST II study

Kaneshka Masdjedi et al.

October 14, 2021

AHEAD OF PRINT

OCT-guided PCI in iatrogenic artery stenosis

Zvonimir Ostojic et al.

October 14, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

AHEAD OF PRINT

Transfemoral transcatheter tricuspid valve replacement after failed leaflet repair

Mirjam G. Wild et al.

October 14, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.

October 1, 2021

AHEAD OF PRINT

Predictors of rotational atherectomy

Sean Fitzgerald et al.